Cargando…
Chagas’ disease: an update on immune mechanisms and therapeutic strategies
The final decade of the 20th century was marked by an alarming resurgence in infectious diseases caused by tropical parasites belonging to the kinetoplastid protozoan order. Among the pathogenic trypanosomatids, some species are of particular interest due to their medical importance. These species i...
Autores principales: | Boscardin, Silvia Beatriz, Torrecilhas, Ana Claudia Troccoli, Manarin, Romina, Revelli, Silvia, Rey, Elena Gonzalez, Tonelli, Renata Rosito, Silber, Ariel Mariano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829005/ https://www.ncbi.nlm.nih.gov/pubmed/20070438 http://dx.doi.org/10.1111/j.1582-4934.2010.01007.x |
Ejemplares similares
-
New Enzymes as Potential Therapeutic Targets for Trypanosomiases and Leishmaniasis
por: Pereira, Claudio Alejandro, et al.
Publicado: (2011) -
Targeting L-Proline Uptake as New Strategy for Anti-chagas Drug Development
por: Fargnoli, Lucía, et al.
Publicado: (2020) -
Cysteine synthase: multiple structures of a key enzyme in cysteine synthesis and a potential drug target for Chagas disease and leishmaniasis
por: Sowerby, Kate, et al.
Publicado: (2023) -
New Biomarker in Chagas Disease: Extracellular Vesicles Isolated from Peripheral Blood in Chronic Chagas Disease Patients Modulate the Human Immune Response
por: Madeira, Rafael Pedro, et al.
Publicado: (2021) -
Congenital Chagas disease: an update
por: Carlier, Yves, et al.
Publicado: (2015)